Rare diseases
Investigational molecules
Locations
Study on Fenebrutinib and Teriflunomide for Adults with Relapsing Multiple Sclerosis
PortugalStudy Comparing Lazertinib and Subcutaneous Amivantamab with Intravenous Amivantamab for Patients with EGFR-mutated Advanced or Metastatic Non-small Cell Lung Cancer
PortugalSafety and Efficacy Study of Efgartigimod PH20 Subcutaneous in Adults with Primary Immune Thrombocytopenia
PortugalStudy on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis
PortugalStudy of Atezolizumab and Tiragolumab for Patients with Unresectable Esophageal Squamous Cell Carcinoma After Chemoradiotherapy
PortugalStudy on the Safety and Effectiveness of Upadacitinib and Prednisolone in Patients with Giant Cell Arteritis
PortugalStudy of Zolbetuximab and CAPOX for Patients with Advanced Gastric or Gastroesophageal Junction Cancer
PortugalStudy comparing iberdomide, daratumumab and dexamethasone versus daratumumab, bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma
PortugalStudy Comparing the Effectiveness and Safety of Macitentan 75 mg and 10 mg for Patients with Pulmonary Arterial Hypertension
PortugalStudy Comparing XL092 and Atezolizumab with Regorafenib for Patients with Metastatic Colorectal Cancer
PortugalStudy of Subcutaneous Nivolumab for Patients with Previously Treated Advanced or Metastatic Clear Cell Kidney Cancer
PortugalStudy on the Effectiveness and Safety of Fenfluramine Hydrochloride for Patients with CDKL5 Deficiency Disorder
PortugalTell us about your condition – we search every trial in Europe and connect you with the right site.
